VBI Vaccines, Inc. - Ordinary Shares (VBIV) Social Stream



VBI Vaccines, Inc. - Ordinary Shares (VBIV): $0.32

0.01 (+3.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add VBIV to Watchlist
Sign Up

Industry: Biotech


Ranked

of 407

in industry

VBI VACCINES INC (VBIV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering VBI VACCINES INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-01 3 $9 $8 $8.5 $0.293 2801.02%
2022-03-07 3 $9 $6 $7.666 $0.293 2516.38%
2022-05-11 2 $8 $6 $6.666 $0.293 2175.09%
2022-08-08 3 $8 $6 $6.666 $0.293 2175.09%
2022-08-09 3 $7 $5 $6 $0.293 1947.78%
2022-11-11 3 $7 $2 $5 $0.293 1606.48%
2023-03-13 2 $6 $2 $4 $0.293 1265.19%
2023-03-14 2 $2 $2 $2 $0.293 582.59%

The Trend in the Analyst Price Target


Over the past 16 months, VBIV's average price target has gone down $6.

VBIV reports an average of 616.31% for its upside potential over the past 44 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-05-09 3 8 6 6.666 1.060 528.87%
2022-08-08 3 8 6 6.666 1.040 540.96%
2022-11-11 2 6 2 4.000 0.597 570.02%
2022-11-11 2 7 2 5.000 0.597 737.52%
2023-03-14 2 2 2 2.000 0.365 447.95%

VBIV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 1 1 0 0 0 2

The Trend in the Broker Recommendations


Over the past 43 weeks, VBIV's average broker recommendation rating worsened by 0.5.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • VBIV has a greater upside potential (average analyst target price relative to current price) than 879.94% of all US stocks.
  • VBI VACCINES INC's average analyst price target is higher than 47.87% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, VBI VACCINES INC's number of analysts covering the stock is higher than 61.32% of them.
  • In the context of Pharmaceutical Products stocks, VBI VACCINES INC's variance in analysts' estimates is lower than -137.74% of them.

Stocks similar to VBI VACCINES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ATNF, ATNX, and GTHX.

Is VBIV a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7284 seconds.